Analyst picks & changes

Chiron Corp.

(CHIR)

Analysts bullish on CHIR's long-term prospects shrugged off disappointing second-quarter results and looked ahead to the potential of

Betaseron

for multiple sclerosis, as well as other products in

Read the full 323 word article

How to gain access

Continue reading with a
two-week free trial.